Recombinant human albumin-human granulocyte colony-stimulating factor
Long-acting recombinant fusion protein used for stimulating neutrophil production
Recombinant human albumin-human granulocyte colony-stimulating factor (rhHSA-G-CSF) is a long-acting recombinant fusion protein that combines domains from human serum albumin (HSA) and granulocyte colony-stimulating factor (G-CSF). It is engineered to enhance granulopoietic activity and prolong therapeutic efficacy through increased serum half-life.
Structure and Composition[edit | edit source]
This biologic agent is composed of two functional components:
- The G-CSF moiety, derived from human granulocyte colony-stimulating factor, a cytokine involved in the regulation of neutrophil production and activity.
- The human serum albumin (HSA) domain, which extends the half-life of the protein by reducing renal clearance and degradation.
Mechanism of Action[edit | edit source]
The G-CSF portion of the fusion protein binds to the G-CSF receptor (CSF3R) on hematopoietic cells in the bone marrow, activating intracellular pathways that:
- Stimulate the proliferation and differentiation of granulocyte precursors.
- Enhance the survival and function of mature neutrophils.
- Promote the mobilization of hematopoietic stem cells into the peripheral blood.
The HSA component contributes to the pharmacokinetics by:
- Increasing serum half-life
- Improving bioavailability
- Reducing the need for frequent dosing, thereby enhancing patient compliance.
Therapeutic Uses[edit | edit source]
Recombinant human albumin-G-CSF is being investigated as an alternative to standard filgrastim and pegfilgrastim in several contexts:
- To reduce the duration of neutropenia following chemotherapy in cancer patients.
- As a stem cell mobilizer prior to hematopoietic stem cell transplantation.
- For use in chronic neutropenic disorders.
Clinical Trials[edit | edit source]
Clinical evaluation is ongoing to assess the safety, tolerability, and efficacy of rhHSA-G-CSF in various populations. Key research goals include:
- Determining optimal dosing regimens
- Comparing efficacy with other long-acting G-CSF analogs
- Evaluating side effect profiles and immunogenicity
You can check for active clinical trials involving this agent at the ClinicalTrials.gov registry.
Advantages of Albumin Fusion Technology[edit | edit source]
Albumin fusion is a widely used strategy to extend the biological activity of therapeutic proteins. Benefits include:
- Enhanced pharmacokinetic profile
- Decreased immunogenicity
- Simplified administration schedules
- Potential cost-effectiveness through reduced frequency of injections
Related Concepts[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD